{"id":"W4402348974","doi":"10.1093/bjd/ljae342","title":"A practical guide to using oral Janus kinase inhibitors for atopic dermatitis from the International Eczema Council","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"ca_institutions":"Queen's University; Innovaderm (Canada)","funders":"Eli Lilly Japan; Sanofi Genzyme; Otsuka Pharmaceutical; Genentech; National Jewish Health; Torii Pharmaceutical; Kiniksa Pharmaceuticals; Taiho Pharmaceutical; Kyowa Kirin Pharmaceutical Development; Castle Biosciences; Celgene; BioCryst; Sun Pharma; Dermira; Valeant Pharmaceuticals International; Pfizer; Incyte; Regeneron Pharmaceuticals; Galderma; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; CSL Behring; LEO Pharma; Gilead Sciences; Sanofi; GlaxoSmithKline; Amgen","keywords":"Medicine; Atopic dermatitis; Dosing; Pharmacovigilance; Omalizumab; Adverse effect; MEDLINE; Expert opinion; Clinical trial; Intensive care medicine; Internal medicine; Dermatology; Immunology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002523079,0.0001355889,0.0004208212,0.00009210297,0.0001195575,0.0001457653,0.0001956302,0.0001459443,0.0002080248],"category_scores_gemma":[0.001948776,0.0001133196,0.0003010501,0.0001263648,0.0001299658,0.0002483818,0.00006872899,0.0003509033,0.00003270113],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000271313,"about_ca_system_score_gemma":0.001464932,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001885691,"about_ca_topic_score_gemma":0.0001698913,"domain_scores_codex":[0.9983265,0.0001173546,0.0006854967,0.0001834844,0.0004327017,0.0002545035],"domain_scores_gemma":[0.9981599,0.0007257456,0.0001494281,0.0001262798,0.0006328871,0.00020573],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"case_report","study_design_scores_codex":[0.0001576077,0.0001363195,0.0209502,0.00005997834,0.0005517264,0.04088454,0.0001784603,0.000008369851,0.000190474,0.0001912237,0.9281422,0.008548931],"study_design_scores_gemma":[0.00196428,0.00006506708,0.01554375,0.001001695,0.0004785917,0.5024213,0.0002455639,0.001726156,0.001188479,0.001074927,0.4741387,0.0001514674],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8930016,0.01589668,0.01445989,0.07188018,0.003513993,0.0004385926,0.0001854618,0.00004833278,0.0005753023],"genre_scores_gemma":[0.9836708,0.0002270054,0.009673726,0.005620278,0.0006441266,0.00001429602,0.00002315672,0.00002488294,0.0001016989],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4615367,"threshold_uncertainty_score":0.4621038,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05098543487854836,"score_gpt":0.3448604056599803,"score_spread":0.293874970781432,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}